Answers are grounded in this paper and cite their sources.
Since 1990, Irish haemophilia A patients have been treated with solvent-detergent(SD)-treated virally inactivated high-purity factor VIII concentrate prepared from plasma from Irish voluntary non-remunerated donors. In 1992, 13 haemophilia A patients developed clinical hepatitis A and a further 17 patients showed serological evidence of recent infection by hepatitis A. All but 3 of these patients had had recent exposure to SD-treated product. A case-control study is underway to determine whether these cases represent transmission through product or environmentally acquired hepatitis A.
No takes yet. Share an insight, caveat, or question.
Lawlor et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: